XOMA

XOMA Operating Cash Flow (Statement)

$6.63MTTM · USD

Period ending:

XOMA FY Cash from OperationsUSD
XOMA FY Cash from Operations1989-12-31: -$18.30M1990-12-31: -$22.60M1991-12-31: -$27.60M1992-12-31: -$34.20M1993-12-31: -$28.90M1994-12-31: -$28.50M1995-12-31: -$28.90M1996-12-31: -$22.40M1997-12-31: -$12.00M1998-12-31: -$37.70M1999-12-31: -$43.10M2000-12-31: -$22.46M2001-12-31: -$22.42M2002-12-31: -$34.84M2003-12-31: -$47.54M2004-12-31: -$44.83M2005-12-31: -$44.19M2006-12-31: -$33.27M2007-12-31: $4.54M2008-12-31: -$32.98M2009-12-31: $7.44M2010-12-31: -$52.54M2011-12-31: -$29.06M2012-12-31: -$40.77M2013-12-31: -$45.92M2014-12-31: -$78.28M2015-12-31: -$30.89M2016-12-31: -$33.69M2017-12-31: $2.69M2018-12-31: -$12.64M2019-12-31: -$285.00K2020-12-31: $10.09M2021-12-31: $22.68M2022-12-31: -$12.88M2023-12-31: -$18.16M2024-12-31: -$13.75M2025-12-31: $2.87M$22.68M-$78.28M
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

XOMA operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

Xoma Royalty Corp Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
2,871,000
-13,748,000
-18,158,000
-12,879,000
22,678,000
10,092,000
-285,000
-12,644,000
2,686,000
-33,689,000
-30,892,000
-78,282,000
-45,915,000
-40,765,000
-29,062,000
-52,537,000
7,435,000
-32,975,000
4,543,000
-33,270,000
-44,190,000
-44,827,000
-47,537,000
-34,841,000
-22,422,000
-22,461,000
-43,100,000
-37,700,000
-12,000,000
-22,400,000
-28,900,000
-28,500,000
-28,900,000
-34,200,000
-27,600,000
-22,600,000
-18,300,000

Compare operating cash flow (statement)

All XOMA financial metrics · XOMA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.